{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:58:15Z","timestamp":1793228295828,"version":"4.5.0"},"reference-count":208,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chemokines are tiny chemotactic cytokines which play a crucial role in pathophysiology by maintaining homeostasis and inflammation. Their role in the tumour microenvironment is very much puzzling because of both pro- and anti-tumourigenic effects. Chemokines have gained much attention today, since it has been recognized that they are game changers in the TME via controlling immune cell recruitment, angiogenesis, metastasis, tumour growth and drug resistance. In this review, we are exploring the role of several chemokines and their receptors in the TME with special focus on immune cell recruitment, immune surveillance, regulation of immune checkpoints and epithelial mesenchymal transition. We are also reviewing the possibility of targeting chemokines along with immunotherapy for better outcome and disease-free survival. A better understanding on the dual role of chemokine in the TME might help to implement novel therapeutic interventions and adopt precision in targeted therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1601756","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:28:34Z","timestamp":1754544514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Chemokines: humble yet mighty players in the tumour microenvironment"],"prefix":"10.3389","volume":"16","author":[{"given":"Hima","family":"Xavier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira Gireesh Moly","family":"Gireesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juvin Ann","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Suboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Biju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshin Thomas","family":"Dominic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suboj","family":"Babykutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3322\/caac.21818","article-title":"Immunosurveillance in clinical cancer management","volume":"74","author":"Kroemer","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tranon.2019.10.001","article-title":"Targeting tumor microenvironment by small-molecule inhibitors","volume":"13","author":"Zhong","year":"2020","journal-title":"Transl Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"CGM.S11285","DOI":"10.4137\/CGM.S11285","article-title":"Regulation of tumor growth and metastasis: the role of tumor microenvironment","volume":"7","author":"Goubran","year":"2014","journal-title":"Cancer Growth Metastasis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B6","article-title":"Radiotherapy and Its Associated Side Effects in Breast, Head and neck, Liver, Thyroid, Non-melanoma skin Cancer and Recent Treatment Strategies","volume":"2","author":"Sachet","year":"2024","journal-title":"Curr Clin Med Educ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/mco2.100","article-title":"Tumor metastasis: Mechanistic insights and therapeutic interventions","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"155293","DOI":"10.1016\/j.phymed.2023.155293","article-title":"Efficacy and safety of Shenqi Fuzheng injection combined with chemotherapy for cancer: an overview of systematic reviews","volume":"125","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03013-3","article-title":"Chemotherapy: a double-edged sword in cancer treatment","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/cancers12020287","article-title":"Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers","volume":"12","author":"Do","year":"2020","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.3390\/ijms23168846","article-title":"Chemokines in primary liver cancer","volume":"23","author":"Zajkowska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.fsi.2019.07.034","article-title":"Unraveling the evolutionary origin of ELR motif using fish CXC chemokine CXCL8","volume":"93","author":"Gangele","year":"2019","journal-title":"Fish Shellfish Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/cancers15010167","article-title":"The role of CXC chemokines in cancer progression","volume":"15","author":"Wu","year":"2022","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00154","article-title":"Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers","volume":"8","author":"Williams","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.134","article-title":"Chemokines in homeostasis and diseases","volume":"15","author":"Chen","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40001-024-01711-z","article-title":"The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review","volume":"29","author":"Abdul-Rahman","year":"2024","journal-title":"Eur J Med Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02159","article-title":"The role of CXC chemokine receptors 1\u20134 on immune cells in the tumor microenvironment","volume":"9","author":"Susek","year":"2018","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"156827","DOI":"10.1016\/j.cyto.2024.156827","article-title":"Unveiling the nexus: The tumor microenvironment as a strategic frontier in viral cancers","volume":"185","author":"Fernandes","year":"2025","journal-title":"Cytokine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/cancers11081080","article-title":"Regulation of immunity in breast cancer","volume":"11","author":"Edechi","year":"2019","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9804","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0160","article-title":"Chemokines in cancer","volume":"2","author":"Chow","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12929-024-00998-8","article-title":"Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies","volume":"31","author":"Li","year":"2024","journal-title":"J BioMed Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.029","article-title":"Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B","volume":"76","author":"Gao","year":"2022","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1431211","article-title":"Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy","volume":"15","author":"Du","year":"2024","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-\u03b2: a master of all T cell trades","volume":"134","author":"Li","year":"2008","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Os","year":"2011","journal-title":"Science"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.v30.i5.30","article-title":"Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression","volume":"30","author":"Mailloux","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2021.08.002","article-title":"Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape","volume":"2","author":"Sarkar","year":"2021","journal-title":"Curr Res Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"75763","DOI":"10.18632\/oncotarget.12409","article-title":"Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2009.01029.x","article-title":"CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma","volume":"23","author":"Maruyama","year":"2010","journal-title":"Dis Esophagus"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1189\/jlb.0910506","article-title":"Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer","volume":"89","author":"Yang","year":"2011","journal-title":"J Leukoc Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2013a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","article-title":"Shaping polarization of tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141392","article-title":"Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages","volume":"10","author":"Incio","year":"2015","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3604","article-title":"Retinoblastoma inactivation induces a protumoral microenvironment via enhanced CCL2 secretion","volume":"79","author":"Li","year":"2019","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"110426","DOI":"10.18632\/oncotarget.22786","article-title":"Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20071493","article-title":"Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment","volume":"409","author":"O\u2019Hayre","year":"2008","journal-title":"Biochem J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3424","article-title":"High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer","volume":"67","author":"Hojo","year":"2007","journal-title":"Cancer Res"},{"key":"B48","article-title":"Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target","volume":"133","author":"Kurt","year":"2023","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.11.014","article-title":"Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor","volume":"117","author":"Li","year":"2020","journal-title":"Mol Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/vaccines4040036","article-title":"The role of myeloid-derived suppressor cells (MDSC) in cancer progression","volume":"4","author":"Umansky","year":"2016","journal-title":"Vaccines"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/cancers12051253","article-title":"CCL2 expression in tumor cells and tumor-infiltrating immune cells shows divergent prognostic potential for bladder cancer patients depending on lymph node stage","volume":"12","author":"Eckstein","year":"2020","journal-title":"Cancers"},{"key":"B52","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms21218412","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","article-title":"Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion","volume":"468","author":"Jiang","year":"2020","journal-title":"Cancer Lett"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-329349","article-title":"CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-\u03baB\/p65 nuclear translocation in pancreatic ductal adenocarcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00227-3","article-title":"Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression","volume":"2","author":"Lopez-Bujanda","year":"2021","journal-title":"Nat Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013101061","article-title":"CXCL5 drives neutrophil recruitment in TH17-mediated GN","volume":"26","author":"Disteldorf","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2016.03.012","article-title":"Chemokine regulation of neutrophil function in tumors","volume":"30","author":"Bonavita","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B58","first-page":"19","article-title":"Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells","volume-title":"Seminars in immunology. Elsevier","author":"Zhou","year":"2018"},{"key":"B59","doi-asserted-by":"publisher","first-page":"106996","DOI":"10.1016\/j.phrs.2023.106996","article-title":"Neutrophils as potential therapeutic targets for breast cancer","volume":"198","author":"Gong","year":"2023","journal-title":"Pharmacol Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0312","article-title":"Targeted deletion of CXCR2 in myeloid cells alters the tumor immune environment to improve antitumor immunity","volume":"9","author":"Yang","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3RI0718-282R","article-title":"Getting TANned: How the tumor microenvironment drives neutrophil recruitment","volume":"105","author":"SenGupta","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s43046-021-00072-6","article-title":"Anti-angiogenesis in cancer therapeutics: the magic bullet","volume":"33","author":"Oguntade","year":"2021","journal-title":"J Egypt Natl Cancer Inst"},{"key":"B63","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/biomedicines5020034","article-title":"The role of angiogenesis in cancer treatment","volume":"5","author":"Rajabi","year":"2017","journal-title":"Biomedicines"},{"key":"B65","doi-asserted-by":"publisher","first-page":"100422","DOI":"10.1016\/j.ctarc.2021.100422","article-title":"Tumor angiogenesis: Current challenges and therapeutic opportunities","volume":"28","author":"Al-Ostoot","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.7150\/jca.44313","article-title":"Angiogenesis in breast cancer progression, diagnosis, and treatment","volume":"11","author":"Madu","year":"2020","journal-title":"J Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/ijms20010096","article-title":"Chemokines and chemokine receptors: orchestrating tumor metastasization","volume":"20","author":"Marcuzzi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10957","article-title":"Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy (Review)","volume":"18","author":"Guo","year":"2019","journal-title":"Oncol Lett"},{"key":"B69","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.3390\/ijms24087262","article-title":"Involvement in tumorigenesis and clinical significance of CXCL1 in reproductive cancers: breast cancer, cervical cancer, endometrial cancer, ovarian cancer and prostate cancer","volume":"24","author":"Korbecki","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2013.0245","article-title":"The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing","volume":"20","author":"Tan","year":"2014","journal-title":"Tissue Eng Part A"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/ijms17111856","article-title":"The role of CC-chemokines in the regulation of angiogenesis","volume":"17","author":"Ridiandries","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.772305","article-title":"Novel pathways for targeting tumor angiogenesis in metastatic breast cancer","volume":"11","author":"Harry","year":"2021","journal-title":"Front Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/cancers12041036","article-title":"The role of CCL21\/CCR7 chemokine axis in breast cancer progression","volume":"12","author":"Rizeq","year":"2020","journal-title":"Cancers"},{"key":"B74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","article-title":"Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition","volume":"18","author":"Glaviano","year":"2025","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2017.08.009","article-title":"EMT: Mechanisms and therapeutic implications","volume":"182","author":"Singh","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2017.06.006","article-title":"EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET","volume":"1868","author":"Goossens","year":"2017","journal-title":"Biochim Biophys Acta BBA-Rev Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2208176","article-title":"Chemokine\/GPCR signaling-mediated EMT in cancer metastasis","volume":"2022","author":"Tian","year":"2022","journal-title":"J Oncol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"154687","DOI":"10.1016\/j.phymed.2023.154687","article-title":"Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT","volume":"112","author":"Xiao","year":"2023","journal-title":"Phytomedicine"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.02.002","article-title":"The chemokine receptor CXCR4 and c-MET cooperatively promote epithelial-mesenchymal transition in gastric cancer cells","volume":"11","author":"Cheng","year":"2018","journal-title":"Transl Oncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-024-08392-y","article-title":"Chemokines and their receptors: predictors of therapeutic potential in tumor microenvironment on esophageal cancer","volume":"69","author":"Huang","year":"2024","journal-title":"Dig Dis Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"115973","DOI":"10.1016\/j.biopha.2023.115973","article-title":"Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)","volume":"170","author":"Tangsiri","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B83","doi-asserted-by":"publisher","first-page":"104119","DOI":"10.1016\/j.cellimm.2020.104119","article-title":"The roles of tumor-associated macrophages in tumor angiogenesis and metastasis","volume":"353","author":"Fu","year":"2020","journal-title":"Cell Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1274474","article-title":"Forces at play: exploring factors affecting the cancer metastasis","volume":"15","author":"Riaz","year":"2024","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/cancers13092053","article-title":"The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.11.015","article-title":"Tumor microenvironment pathways: cross regulation in breast cancer metastasis","volume":"9","author":"Malla","year":"2022","journal-title":"Genes Dis"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.574667","article-title":"The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06648-8","article-title":"An updated review on the role of the CXCL8-CXCR1\/2 axis in the progression and metastasis of breast cancer","volume":"48","author":"Mishra","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.15.618571","article-title":"Intratumoral CXCL12 gradients contextualize tumor cell invasion, migration and immune suppression in breast cancer","author":"Anastasiadou","year":"2024","journal-title":"bioRxiv"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2014.01.015","article-title":"Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans","volume":"61","author":"Kamalakar","year":"2014","journal-title":"Bone"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.18632\/oncotarget.1426","article-title":"Chemokines in tumor progression and metastasis","volume":"4","author":"Sarvaiya","year":"2013","journal-title":"Oncotarget"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00313","article-title":"Role of tumor-derived chemokines in osteolytic bone metastasis","volume":"9","author":"Coniglio","year":"2018","journal-title":"Front Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms22020843","article-title":"The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors\u2014a review of literature","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.05.036","article-title":"The hypoxic tumor microenvironment: A driving force for breast cancer progression","volume":"1863","author":"Semenza","year":"2016","journal-title":"Biochim Biophys Acta BBA-Mol Cell Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"789414","DOI":"10.1155\/2015\/789414","article-title":"Interleukin-1 \u03b2 Affects MDAMB231 breast cancer cell migration under hypoxia: role of HIF-1 \u03b1 and NF \u03ba B transcription factors","volume":"2015","author":"Filippi","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1063051","article-title":"Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point","volume":"13","author":"Thomas","year":"2023","journal-title":"Front Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0138","article-title":"Concise review: cancer cells, cancer stem cells, and mesenchymal stem cells: influence in cancer development","volume":"6","author":"Papaccio","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/cancers12123765","article-title":"Breast cancer stem cells: biomarkers, identification and isolation methods, regulating mechanisms, cellular origin, and beyond","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells\u2014origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/sctm.18-0123","article-title":"Concise reviews: cancer stem cell targeted therapies: toward clinical success","volume":"8","author":"Desai","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.jbo.2019.100253","article-title":"The role of CXCR4 in multiple myeloma: Cells\u2019 journey from bone marrow to beyond","volume":"17","author":"Ullah","year":"2019","journal-title":"J Bone Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8716","article-title":"Interplay between inflammatory tumor microenvironment and cancer stem cells (Review)","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"B107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20517\/cdr.2019.10","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.07.005","article-title":"Targeted therapy for breast cancer","volume":"183","author":"Mohamed","year":"2013","journal-title":"Am J Pathol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.3390\/cancers14174251","article-title":"CC chemokine ligand-2: a promising target for overcoming anticancer drug resistance","volume":"14","author":"Shi","year":"2022","journal-title":"Cancers"},{"key":"B110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cas.14230","article-title":"Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K\/Akt\/mTOR in breast cancer","volume":"111","author":"Li","year":"2020","journal-title":"Cancer Sci"},{"key":"B111","unstructured":"Blockade of CCL2 expression overcomes intrinsic PD-1\/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer\n          \n          2878\n          \n            \n              Choi\n              J\n            \n            \n              Lee\n              HJ\n            \n            \n              Yoon\n              S\n            \n            \n              Ryu\n              HM\n            \n            \n              Lee\n              E\n            \n            \n              Jo\n              Y\n            \n          \n          33042623\n          Amer J Canc Res\n          10\n          2020"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.20900\/immunometab20210007","article-title":"Diverse roles of Akt in T cells","volume":"3","author":"Abdullah","year":"2021","journal-title":"Immunometabolism"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3014","article-title":"Chemokines and chemokine receptors: A new strategy for breast cancer therapy","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.3390\/cancers13236132","article-title":"Multifaceted roles of chemokines and chemokine receptors in tumor immunity","volume":"13","author":"Matsuo","year":"2021","journal-title":"Cancers"},{"key":"B115","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun"},{"key":"B117","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/v16020302","article-title":"The chemokine CXCL14 as a potential immunotherapeutic agent for cancer therapy","volume":"16","author":"Giacobbi","year":"2024","journal-title":"Viruses"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.03.004","article-title":"Chemokines and cancer: new immune checkpoints for cancer therapy","volume":"51","author":"Karin","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2022.12.002","article-title":"Role of T cells in cancer immunotherapy: Opportunities and challenges","volume":"1","author":"Ahmed","year":"2023","journal-title":"Cancer Pathog Ther"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2358590","DOI":"10.1080\/2162402X.2024.2358590","article-title":"CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival","volume":"13","author":"Nie","year":"2024","journal-title":"OncoImmunology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.3390\/ijms25126532","article-title":"Chemokines and cytokines in immunotherapy of melanoma and other tumors: from biomarkers to therapeutic targets","volume":"25","author":"Reschke","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001948","article-title":"CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors","volume":"9","author":"Karaki","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell\u2013dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100004","article-title":"Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells","volume":"207","author":"Harada","year":"2010","journal-title":"J Exp Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"115976","DOI":"10.1016\/j.biopha.2023.115976","article-title":"Polysaccharides regulate Th1\/Th2 balance: a new strategy for tumor immunotherapy","volume":"170","author":"Shang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/327470","article-title":"T helper lymphocyte subsets and plasticity in autoimmunity and cancer: an overview","volume":"2015","author":"Ivanova","year":"2015","journal-title":"BioMed Res Int"},{"key":"B127","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1126\/science.1185837","article-title":"Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21","volume":"328","author":"Shields","year":"2010","journal-title":"Science"},{"key":"B129","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.intimp.2020.106939","article-title":"Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment","volume":"88","author":"Li","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01930","article-title":"Chemokine-induced macrophage polarization in inflammatory conditions","volume":"9","author":"Ruytinx","year":"2018","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0279-0","article-title":"CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization","volume":"17","author":"Li","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13765","article-title":"Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy","volume":"172","author":"Wu","year":"2024","journal-title":"Immunology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00262-024-03650-4","article-title":"Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization","volume":"73","author":"Xu","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B135","doi-asserted-by":"publisher","first-page":"15827","DOI":"10.3390\/ijms232415827","article-title":"Diverse neutrophil functions in cancer and promising neutrophil-based cancer therapies","volume":"23","author":"Sounbuli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2625","article-title":"Inhibition of MDSC trafficking with SX-682, a CXCR1\/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models","volume":"26","author":"Greene","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.02.002","article-title":"Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8\/CXCR2 signaling","volume":"33","author":"Kwong","year":"2025","journal-title":"Mol Ther"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp Mol Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5918","article-title":"Distinct circulating cytokine\/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non-small cell lung cancer","volume":"12","author":"Hu","year":"2023","journal-title":"Cancer Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1096\/fj.201802067RR","article-title":"Dual blockade of CXCL12-CXCR4 and PD-1\u2013PD-L1 pathways prolongs survival of ovarian tumor\u2013bearing mice by prevention of immunosuppression in the tumor microenvironment","volume":"33","author":"Zeng","year":"2019","journal-title":"FASEB J"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-020-01235-8","article-title":"The complexity of targeting chemokines to promote a tumor immune response","volume":"43","author":"Strazza","year":"2020","journal-title":"Inflammation"},{"key":"B142","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000326","article-title":"Simultaneous inhibition of CXCR1\/2, TGF-\u03b2, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity","volume":"8","author":"Horn","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2418985122","article-title":"Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1","volume":"122","author":"Mok","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v4i3.992","article-title":"Estimate the relationship between CXCR4-SDF-1 axis and inhibitory molecules (CTLA4 and PD-1) in patients with colon cancer","volume":"4","author":"Abdul-Huseen","year":"2024","journal-title":"Narra J"},{"key":"B145","doi-asserted-by":"publisher","first-page":"106391","DOI":"10.1016\/j.jinf.2024.106391","article-title":"Immune checkpoint blockade in experimental bacterial infections","volume":"90","author":"Henriksen","year":"2025","journal-title":"J Infect"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0486","article-title":"Reprogramming the intrahepatic cholangiocarcinoma immune microenvironment by chemotherapy and CTLA-4 blockade enhances anti\u2013PD-1 therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.5114\/pja.2023.131708","article-title":"The role of cytokines and chemokines in the inflammatory response","volume":"10","author":"Harvanov\u00e1","year":"2023","journal-title":"Alergol Pol-Pol J Allergol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of chemokines in the crosstalk between tumor and tumor-associated macrophages","volume":"23","author":"Qin","year":"2022","journal-title":"Clin Exp Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15362","article-title":"Post-transcriptional regulation of C-C motif chemokine ligand 2 expression by ribosomal protein L22 during LPS-mediated inflammation","volume":"287","author":"Das","year":"2020","journal-title":"FEBS J"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2081","article-title":"Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)","volume":"12","author":"Sun","year":"2011","journal-title":"Nat Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00224","article-title":"Atypical chemokine receptors and their roles in the resolution of the inflammatory response","volume":"7","author":"Bonecchi","year":"2016","journal-title":"Front Immunol"},{"key":"B153","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.2014010062","article-title":"Regulation of chemokine expression in the tumor microenvironment","volume":"34","author":"Gorbachev","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"B154","first-page":"63","article-title":"Chemokines sound the alarmin: The role of atypical chemokine in inflammation and cancer","volume-title":"Seminars in immunology","author":"Borroni","year":"2018"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1111960","article-title":"Prospects for targeting ACKR1 in cancer and other diseases","volume":"14","author":"Crawford","year":"2023","journal-title":"Front Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861931","article-title":"The role of atypical chemokine receptor D6 (ACKR2) in physiological and pathological conditions; friend, foe, or both","volume":"13","author":"Gowhari Shabgah","year":"2022","journal-title":"Front Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149039","article-title":"Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation","volume":"112","author":"Loos","year":"2008","journal-title":"Blood J Am Soc Hematol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.3390\/cancers13174247","article-title":"The role of post-translational modifications of chemokines by CD26 in cancer","volume":"13","author":"De Zutter","year":"2021","journal-title":"Cancers"},{"key":"B160","article-title":"Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells","volume":"60","author":"Xu","year":"2000","journal-title":"Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020898","article-title":"Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells","volume":"6","author":"Boudot","year":"2011","journal-title":"PloS One"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0186-z","article-title":"Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells","volume":"117","author":"Sengupta","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp Mol Med"},{"key":"B165","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/antib9030034","article-title":"Monoclonal antibodies in cancer therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies"},{"key":"B166","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1041","article-title":"2018 Nobel Prize in physiology or medicine","volume":"7","author":"Smyth","year":"2018","journal-title":"Clin Transl Immunol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.3390\/cancers13246317","article-title":"Chemokines in the landscape of cancer immunotherapy: how they and their receptors can be used to turn cold tumors into hot ones","volume":"13","author":"Karin","year":"2021","journal-title":"Cancers"},{"key":"B168","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12935-025-03765-3","article-title":"CXCL2: a key player in the tumor microenvironment and inflammatory diseases","volume":"25","author":"Lv","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B169","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/biomedicines11102655","article-title":"The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as potential prognosis markers in cervical cancer: Evidence of E6\/E7 from HPV16 and 18 in chemokines regulation","volume":"11","author":"Fernandez-Avila","year":"2023","journal-title":"Biomedicines"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322744","article-title":"Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism","volume":"71","author":"Sun","year":"2022","journal-title":"Gut"},{"key":"B171","doi-asserted-by":"publisher","first-page":"27426","DOI":"10.1038\/srep27426","article-title":"CXCL3 contributes to CD133+ CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1\/2 phosphorylation","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S148772","article-title":"The clinical significance of CXCL5 in non-small cell lung cancer","volume":"10","author":"Wu","year":"2017","journal-title":"OncoTargets Ther"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92466","article-title":"Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone","volume":"128","author":"Roca","year":"2018","journal-title":"J Clin Invest"},{"key":"B175","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41389-020-00249-z","article-title":"CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils","volume":"9","author":"Mao","year":"2020","journal-title":"Oncogenesis"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.11.004","article-title":"CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p","volume":"97","author":"Li","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00307","article-title":"Activation of CXCL6\/CXCR1\/2 axis promotes the growth and metastasis of osteosarcoma cells in vitro and in vivo","volume":"10","author":"Liu","year":"2019","journal-title":"Front Pharmacol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.276","article-title":"CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas","volume":"117","author":"Dufies","year":"2017","journal-title":"Br J Cancer"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.914730","article-title":"Multifaceted roles of chemokine CXC motif ligand 7 in inflammatory diseases and cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.03.181","article-title":"CXCL8 is associated with the recurrence of patients with acute myeloid leukemia and cell proliferation in leukemia cell lines","volume":"499","author":"Li","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.934","article-title":"CXCL9: evidence and contradictions for its role in tumor progression","volume":"5","author":"Ding","year":"2016","journal-title":"Cancer Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-014-9593-0","article-title":"The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2","volume":"45","author":"Lan","year":"2014","journal-title":"J Mol Histol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0088","article-title":"CXCL10 recruitment of \u0393\u03b4 T cells into the hypoxic bone marrow environment leads to IL17 expression and multiple myeloma progression","volume":"11","author":"Wang","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B184","doi-asserted-by":"publisher","first-page":"10732748241241162","DOI":"10.1177\/10732748241241162","article-title":"The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets","volume":"31","author":"Wang","year":"2024","journal-title":"Cancer Control"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/life11121282","article-title":"CXCL13 in cancer and other diseases: biological functions, clinical significance, and therapeutic opportunities","volume":"11","author":"Gao","year":"2021","journal-title":"Life"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00471","article-title":"CXCL13 and its receptor CXCR5 in cancer: inflammation, immune response, and beyond","volume":"10","author":"Kazanietz","year":"2019","journal-title":"Front Endocrinol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2124390","article-title":"Plasma chemokine CCL2 and its receptor CCR2 concentrations as diagnostic biomarkers for breast cancer patients","volume":"2018","author":"Lubowicka","year":"2018","journal-title":"BioMed Res Int"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-0441-4","article-title":"CCL3\u2013CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways","volume":"100","author":"Kodama","year":"2020","journal-title":"Lab Invest"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/biomedicines10071612","article-title":"The chemokine CCL4 stimulates angiopoietin-2 expression and angiogenesis via the MEK\/ERK\/STAT3 pathway in oral squamous cell carcinoma","volume":"10","author":"Lu","year":"2022","journal-title":"Biomedicines"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/medicina57111141","article-title":"The role of chemokines in cervical cancers","volume":"57","author":"Garrido","year":"2021","journal-title":"Medicina (Mex)"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3390\/cancers12071765","article-title":"The CCL5\/CCR5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3133-8","article-title":"Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients","volume":"36","author":"Wertel","year":"2015","journal-title":"Tumor Biol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00432-024-05832-0","article-title":"Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis","volume":"150","author":"Gan","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.7150\/thno.53749","article-title":"Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"B195","unstructured":"Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape - PubMed\n          \n          16644201"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1002\/pro.70032","article-title":"The multifaceted role of XCL1 in health and disease","volume":"34","author":"Syed","year":"2025","journal-title":"Protein Sci"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-016-0395-9","article-title":"Role of CX3CL1 in diseases","volume":"64","author":"Liu","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384784","article-title":"CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease","volume":"120","author":"Dairaghi","year":"2012","journal-title":"Blood J Am Soc Hematol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019884863","article-title":"Mogamulizumab: an anti-CC chemokine receptor 4 antibody for T-cell lymphomas","volume":"54","author":"Moore","year":"2020","journal-title":"Ann Pharmacother"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1265","article-title":"CCL2\/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy","volume":"74","author":"Ma","year":"2014","journal-title":"Cancer Res"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.06.009","article-title":"Chemokine biology on immune checkpoint\u2013targeted therapies","volume":"137","author":"Letourneur","year":"2020","journal-title":"Eur J Cancer"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03172-5","article-title":"Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment","volume":"143","author":"Wu","year":"2019","journal-title":"J Neurooncol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","article-title":"Challenges and new technologies in adoptive cell therapy","volume":"16","author":"Zhang","year":"2023","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1260470","article-title":"Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development","volume":"14","author":"P\u00e9rez-Amill","year":"2023","journal-title":"Front Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"117229","DOI":"10.1016\/j.biopha.2024.117229","article-title":"Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies","volume":"178","author":"Cheng","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B206","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00262-024-03909-w","article-title":"CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors","volume":"74","author":"Tian","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-24-0435","article-title":"Characteristics of a CCL21 gene\u2013modified dendritic cell vaccine utilized for a clinical trial in non\u2013small cell lung cancer","volume":"24","author":"Oh","year":"2025","journal-title":"Mol Cancer Ther"},{"key":"B208","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s11658-023-00483-4","article-title":"CRISPR applications in cancer diagnosis and treatment","volume":"28","author":"Wang","year":"2023","journal-title":"Cell Mol Biol Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1601756\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:28:37Z","timestamp":1754544517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1601756\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":208,"alternative-id":["10.3389\/fimmu.2025.1601756"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1601756","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"article-number":"1601756"}}